MDIC Announces Pathology ‘Collaborative Community’ With FDA Involvement
This is MDIC’s third collaborative community, following groups for the US FDA’s Case for Quality and health technology.
You may also be interested in...
The US agency is participating in collaborative communities centered around eye health and the development of real-world evidence, representing the first two of what the agency hopes will be at least 10 communities by the end of 2020.
The decision limits US FDA discretion in determining how to regulate products that seem to meet both drug and device standards.
The Bio-Console 560 extracorporeal blood pumping console is being recalled over reports it could lose power during bypass surgery, which could lead to organ or neural dysfunction, blood clots, or even death.